Angiotech Pharmaceuticals (ANPI) Issues Update on TAXUS Liberte Stent
Tweet Send to a Friend
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI) announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


